• Profile
Close

Transjugular intrahepatic portosystemic shunt for portal hypertension in hepatocellular carcinoma with portal vein tumor thrombus

Cardiovascular and Interventional Radiology Aug 11, 2017

Qiu B, et al. – Researchers sought to evaluate utility and safety of transjugular intrahepatic portosystemic shunt (TIPS) for treatment of symptomatic portal hypertension in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). TIPS was recommended as a safe and feasible treatment option for symptomatic portal hypertension in HCC with PVTT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay